Lumenis utilizes Cognizant's MedVantage Complaint Management Solution to improve customer service

Cognizant (NASDAQ: CTSH) today announced that Lumenis Ltd. (NASDAQ: LMNS), the world's largest energy-based medical device company for aesthetic, surgical and ophthalmology applications, has deployed Cognizant MedVantage™, a cloud-based integrated complaint handling solution.

Lumenis' ground-breaking products using laser, intense pulsed light (IPL) and radio frequency (RF) technologies have redefined medical treatments and set numerous technological and clinical benchmarks and standards. By utilizing Cognizant's MedVantage™ Complaint Management Solution, device and other issues are automatically and precisely tracked, classified and maintained online from start to finish for improved service, efficiency and reporting.

"Lumenis has an uncompromising commitment to improving the health and well-being of our patients. The Cognizant MedVantage solution integrates seamlessly with our existing Salesforce.com infrastructure and provides all of our stakeholders with a critical end-to-end complaint management solution," said Amir Belferman, Global CIO, Lumenis. "MedVantage enables us to not only manage product complaints but also related adverse events, Medical Device Reporting (MDR)/Vigilance reporting, corrective and preventive action (CAPA) activities, and internal/external audit tracking. Our regional offices recently went 'live' with this new solution, enhancing our ability to analyze global post market data from anywhere in the world."

"This global access to data will help our engineering and R&D departments make more rapid product improvement decisions, ultimately affecting our customers' satisfaction and their patients' outcomes," said Yossi Sabach, Project Manager of Global IT Complaint Management, Lumenis. "With this solution, we have expanded global outreach and will continue to do so going forward."

"With Lumenis deploying more of its innovative medical devices worldwide, it is leveraging the scale of the cloud to implement a highly collaborative digital solution that can be quickly adopted in multiple markets," said Shankar Narayanan, Vice President and Global Markets Leader of the Life Sciences practice at Cognizant. "Maintaining a standard of rapid response and agility in today's quickly changing regulatory environment is critical to meeting and exceeding customer expectations. MedVantage, one of the digital solutions within our Life Sciences practice, is specifically designed as a turnkey solution to provide distinct scale, cost and business advantages compared to complex traditional systems."

Source:

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Lumenis Inc.. (2019, June 19). Lumenis utilizes Cognizant's MedVantage Complaint Management Solution to improve customer service. News-Medical. Retrieved on November 02, 2024 from https://www.news-medical.net/news/20150603/Lumenis-utilizes-Cognizants-MedVantage-Complaint-Management-Solution-to-improve-customer-service.aspx.

  • MLA

    Lumenis Inc.. "Lumenis utilizes Cognizant's MedVantage Complaint Management Solution to improve customer service". News-Medical. 02 November 2024. <https://www.news-medical.net/news/20150603/Lumenis-utilizes-Cognizants-MedVantage-Complaint-Management-Solution-to-improve-customer-service.aspx>.

  • Chicago

    Lumenis Inc.. "Lumenis utilizes Cognizant's MedVantage Complaint Management Solution to improve customer service". News-Medical. https://www.news-medical.net/news/20150603/Lumenis-utilizes-Cognizants-MedVantage-Complaint-Management-Solution-to-improve-customer-service.aspx. (accessed November 02, 2024).

  • Harvard

    Lumenis Inc.. 2019. Lumenis utilizes Cognizant's MedVantage Complaint Management Solution to improve customer service. News-Medical, viewed 02 November 2024, https://www.news-medical.net/news/20150603/Lumenis-utilizes-Cognizants-MedVantage-Complaint-Management-Solution-to-improve-customer-service.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
U.S. PTO reexamining Lumenis patents